Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer
出版年份 2021 全文链接
标题
Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer
作者
关键词
-
出版物
Cells
Volume 10, Issue 5, Pages 1176
出版商
MDPI AG
发表日期
2021-05-12
DOI
10.3390/cells10051176
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Role of polo-like kinase 4 (PLK4) in epithelial cancers and recent progress in its small molecule targeting for cancer management
- (2021) Debra R. Garvey et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation
- (2021) Hailing Zhang et al. BMC CANCER
- Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
- (2021) Xiaoyang Zhang et al. Frontiers in Oncology
- Direct interaction between CEP85 and STIL mediates PLk4-driven directed cell migration
- (2020) Yi Liu et al. JOURNAL OF CELL SCIENCE
- Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
- (2020) Daixi Ren et al. Molecular Cancer
- Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patients
- (2020) Oksana Goroshchuk et al. Scientific Reports
- Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
- (2020) Eleni Maniati et al. Cell Reports
- Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 Expression
- (2020) Jungwhoi Lee et al. Cancers
- Bimodal magnetic resonance and optical imaging of extracellular matrix remodelling by orthotopic ovarian tumours
- (2020) Filip Bochner et al. BRITISH JOURNAL OF CANCER
- Peptidomimetic Polo‐Box‐Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor
- (2020) Merissa Baxter et al. ChemMedChem
- Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma
- (2020) Eman H. Yousef et al. TUMOR BIOLOGY
- PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma
- (2020) Wenhu Li et al. Cancer Medicine
- Aurora Borealis (Bora), Which Promotes Plk1 Activation by Aurora A, Has an Oncogenic Role in Ovarian Cancer
- (2020) Alfonso Parrilla et al. Cancers
- Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma
- (2020) Roberta Affatato et al. Cancers
- Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics
- (2020) Dominic P. Byrne et al. BIOCHEMICAL JOURNAL
- YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects
- (2020) Yongxia Zhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches
- (2020) Razia Zakarya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A new mouse model of ovarian cancer metastasis
- (2020) Alexandra Le Bras LAB ANIMAL
- Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways
- (2020) Hongjun Fei et al. Journal of Ovarian Research
- In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
- (2020) Olga Kim et al. PLoS Genetics
- Phosphorylation of PLK3 Is Controlled by Protein Phosphatase 6
- (2020) Cecilia Aquino Perez et al. Cells
- The CINs of Polo-Like Kinase 1 in Cancer
- (2020) Chelsea E. Cunningham et al. Cancers
- The Prognostic Relevance of the Proliferation Markers Ki-67 and Plk1 in Early-Stage Ovarian Cancer Patients With Serous, Low-Grade Carcinoma Based on mRNA and Protein Expression
- (2020) Franz Rödel et al. Frontiers in Oncology
- Non-mitotic functions of polo-like kinases in cancer cells
- (2020) Christopher A. Raab et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Transcriptome Remodeling in Gradual Development of Inverse Resistance between Paclitaxel and Cisplatin in Ovarian Cancer Cells
- (2020) Jolanta Szenajch et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanism and Regulation of Centriole and Cilium Biogenesis
- (2019) David K. Breslow et al. Annual Review of Biochemistry
- Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer
- (2019) Chunhao Lin et al. Cancer Management and Research
- The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
- (2019) Guillermo de Cárcer Genes
- Polo‑like kinase�4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma
- (2019) Jia Wang et al. ONCOLOGY REPORTS
- Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer
- (2019) Amreena Suri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role for polo-like kinase 4 in mediation of cytokinesis
- (2019) Michael F. Press et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
- (2019) San-Nung Chen et al. International Journal of Environmental Research and Public Health
- Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability
- (2019) Monika Raab et al. NEOPLASIA
- Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial
- (2019) Zachary W. Veitch et al. BRITISH JOURNAL OF CANCER
- Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes
- (2019) Rita Sofia Garcia Ribeiro et al. International Journal of Nanomedicine
- Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer’s disease model mice
- (2019) Ji Soo Lee et al. PLoS One
- Atypical function of a centrosomal module in WNT signalling drives contextual cancer cell motility
- (2019) Yi Luo et al. Nature Communications
- Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics
- (2019) Na Li et al. EPMA Journal
- PLK4: a promising target for cancer therapy
- (2019) Yi Zhao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy
- (2019) Max Fleischmann et al. Frontiers in Oncology
- The molecular origin and taxonomy of mucinous ovarian carcinoma
- (2019) Dane Cheasley et al. Nature Communications
- Phase separation of Polo-like kinase 4 by autoactivation and clustering drives centriole biogenesis
- (2019) Jung-Eun Park et al. Nature Communications
- The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer
- (2019) Matthew Schwede et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Polo‐like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non‐small cell lung cancer
- (2019) Qin Zhou et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer
- (2018) Tao Han et al. BIOMEDICINE & PHARMACOTHERAPY
- TPX2 promotes cell proliferation and migration via PLK1 in OC
- (2018) Shuyun Ma et al. Cancer Biomarkers
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Comprehensive and Integrative Analysis Reveals the Diagnostic, Clinicopathological and Prognostic Significance of Polo-Like Kinase 1 in Hepatocellular Carcinoma
- (2018) Peng Lin et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The latest animal models of ovarian cancer for novel drug discovery
- (2018) Elizabeth Magnotti et al. Expert Opinion on Drug Discovery
- Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer
- (2018) Yuquan Xie et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Precious GEMMs: emergence of faithful models for ovarian cancer research
- (2018) Sarah Stuckelberger et al. JOURNAL OF PATHOLOGY
- Centriole Overduplication is the Predominant Mechanism Leading to Centrosome Amplification in Melanoma
- (2018) Ryan A. Denu et al. MOLECULAR CANCER RESEARCH
- Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
- (2018) Masanori Kawakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway
- (2018) Xiangdong Tian et al. Cell Death & Disease
- Potential tumor suppressing role of microRNA-545 in epithelial ovarian cancer
- (2018) Xibiao Jia et al. Oncology Letters
- PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
- (2018) Monika Raab et al. Nature Communications
- Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis
- (2018) Ke Zhang et al. Journal of Ovarian Research
- Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of polo-like kinase 1 and microtubule dynamics
- (2018) Sabrina Noack et al. Oncotarget
- Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling
- (2018) Elizabeth M. Matthew et al. NEOPLASIA
- Phosphorylation of synaptic GTPase-activating protein (synGAP) by polo-like kinase (Plk2) alters the ratio of its GAP activity toward HRas, Rap1 and Rap2 GTPases
- (2018) Ward G. Walkup et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PLK4 is a microtubule-associated protein that self assembles promoting de novo MTOC formation
- (2018) Susana Montenegro Gouveia et al. JOURNAL OF CELL SCIENCE
- Copy number signatures and mutational processes in ovarian carcinoma
- (2018) Geoff Macintyre et al. NATURE GENETICS
- Polo-like kinases and acute leukemia
- (2018) Oksana Goroshchuk et al. ONCOGENE
- Plk1 overexpression induces chromosomal instability and suppresses tumor development
- (2018) Guillermo de Cárcer et al. Nature Communications
- Regulating a key mitotic regulator, polo‐like kinase 1 (PLK1)
- (2018) Erica G. Colicino et al. Cytoskeleton
- PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas
- (2018) Yuan Ren et al. JOURNAL OF CLINICAL INVESTIGATION
- High LIN28A and PLK4 co‑expression is associated with poor prognosis in epithelial ovarian cancer
- (2018) Yao He et al. Molecular Medicine Reports
- YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect
- (2018) Qian Lei et al. Cell Death & Disease
- MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway
- (2018) Jie Bao et al. Cell Death & Disease
- PLK4: a link between centriole biogenesis and cancer
- (2017) Radhika Radha Maniswami et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Kinases Involved in Both Autophagy and Mitosis
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Establishment of two ovarian cancer orthotopic xenograft mouse models for in vivo imaging: A comparative study
- (2017) Jing Guo et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miRNAs and ovarian cancer: An overview
- (2017) Bornali Deb et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients
- (2017) Iryna Kolosenko et al. JOURNAL OF CONTROLLED RELEASE
- Polo-like kinase-1 immunoreactivity is associated with metastases in cutaneous melanoma
- (2017) Maciej Kaczorowski et al. JOURNAL OF CUTANEOUS PATHOLOGY
- High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease
- (2017) Yali Zhai et al. JOURNAL OF PATHOLOGY
- Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis
- (2017) Guillermo de Cárcer et al. NATURE MEDICINE
- Playing polo during mitosis: PLK1 takes the lead
- (2017) G Combes et al. ONCOGENE
- Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation
- (2017) Yan-Fang Tao et al. ONCOLOGY REPORTS
- Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer
- (2017) Jacqueline M. Mason et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PLK1, A Potential Target for Cancer Therapy
- (2017) Zhixian Liu et al. Translational Oncology
- Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway
- (2017) Xiaoyu Ma et al. Nature Communications
- Regulatory functional territory of PLK-1 and their substrates beyond mitosis
- (2017) Shiv Kumar et al. Oncotarget
- PLK1 Activation in Late G2 Sets Up Commitment to Mitosis
- (2017) Lilia Gheghiani et al. Cell Reports
- The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
- (2017) Zheng Fu et al. Cancers
- Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
- (2017) Andrea Morandi et al. Frontiers in Oncology
- Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes
- (2016) Ryusuke Murakami et al. AMERICAN JOURNAL OF PATHOLOGY
- PLK-1: Angel or devil for cell cycle progression
- (2016) Shiv Kumar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Genetic depletion of Polo-like kinase 1 leads to embryonic lethality due to mitotic aberrancies
- (2016) Paulina Wachowicz et al. BIOESSAYS
- Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer
- (2016) Ryan A. Denu et al. BMC CANCER
- Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma
- (2016) Vladimir Amani et al. BMC CANCER
- Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer
- (2016) Baochi Ou et al. CANCER LETTERS
- Plk4 Promotes Cancer Invasion and Metastasis through Arp2/3 Complex Regulation of the Actin Cytoskeleton
- (2016) Karineh Kazazian et al. CANCER RESEARCH
- CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma
- (2016) J. Walton et al. CANCER RESEARCH
- Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study
- (2016) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
- (2016) Rosie Elizabeth Ann Gutteridge et al. MOLECULAR CANCER THERAPEUTICS
- Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy
- (2016) Franz Rödel et al. Oncotarget
- DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases
- (2016) Jing Xu et al. Oncotarget
- MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer
- (2016) Fei Liu et al. Oncotarget
- Genetic mutations associated with metastatic clear cell renal cell carcinoma
- (2016) Zhongjun Li et al. Oncotarget
- Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts
- (2016) Ines Lohse et al. Oncotarget
- An Advanced Orthotopic Ovarian Cancer Model in Mice for Therapeutic Trials
- (2016) Ying Zhang et al. Biomed Research International
- Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling
- (2016) Jianguo Wu et al. eLife
- Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy
- (2016) Zhenhua Li et al. Journal of Cancer
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Optimized Plk1 PBD Inhibitors Based on Poloxin Induce Mitotic Arrest and Apoptosis in Tumor Cells
- (2015) Andrej Scharow et al. ACS Chemical Biology
- Polo-like kinase and its inhibitors: Ready for the match to start?
- (2015) Neil D. Palmisiano et al. AMERICAN JOURNAL OF HEMATOLOGY
- It's Totally Tubular...Riding The New Wave of Ovarian Cancer Research
- (2015) R. Perets et al. CANCER RESEARCH
- MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer
- (2015) Harriet E. Gee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer
- (2015) Jie Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis
- (2015) Özdemirhan Serçin et al. NATURE CELL BIOLOGY
- Understanding the Polo Kinase machine
- (2015) V Archambault et al. ONCOGENE
- The role of Plk3 in oncogenesis
- (2015) C Helmke et al. ONCOGENE
- Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis
- (2015) RUITAO ZHANG et al. ONCOLOGY REPORTS
- Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer
- (2015) T. G. Tut et al. PLoS One
- Reversible centriole depletion with an inhibitor of Polo-like kinase 4
- (2015) Y. L. Wong et al. SCIENCE
- Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment
- (2015) Xiaoqi Liu Translational Oncology
- Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy
- (2015) Kyung S. Lee et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73
- (2015) Hai Lu et al. OncoTargets and Therapy
- Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer
- (2015) Shengzhe Zhang et al. Scientific Reports
- Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse
- (2015) Paula A. Coelho et al. Open Biology
- PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
- (2015) Shiv Kumar et al. Biomed Research International
- Multiple Requirements of PLK1 during Mouse Oocyte Maturation
- (2015) Petr Solc et al. PLoS One
- Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer
- (2015) Helen M. Coley et al. Oncotarget
- Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy
- (2015) Frank Louwen et al. Oncotarget
- Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles
- (2015) Birgit Spänkuch et al. NEOPLASIA
- CAND1 Promotes PLK4-Mediated Centriole Overduplication and Is Frequently Disrupted in Prostate Cancer
- (2015) Nina Korzeniewski et al. NEOPLASIA
- Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
- (2014) Andrew J. Holland et al. CANCER CELL
- Plk2 regulates mitotic spindle orientation and mammary gland development
- (2014) E. Villegas et al. DEVELOPMENT
- Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance
- (2014) Mihaela Marina Frontiers in Bioscience-Landmark
- A mouse model for endometrioid ovarian cancer arising from the distal oviduct
- (2014) Paul H. van der Horst et al. INTERNATIONAL JOURNAL OF CANCER
- A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development
- (2014) Cheryl A Sherman-Baust et al. JOURNAL OF PATHOLOGY
- Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State
- (2014) Z. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer
- (2014) Kazuya Shinmura et al. MOLECULAR BIOLOGY REPORTS
- Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells
- (2014) LI YING LIU et al. Molecular Medicine Reports
- Sequential Cdk1 and Plk1 phosphorylation of caspase-8 triggers apoptotic cell death during mitosis
- (2014) Yves Matthess et al. Molecular Oncology
- Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1
- (2014) Monika Raab et al. Molecular Oncology
- Oncogene-like induction of cellular invasion from centrosome amplification
- (2014) Susana A. Godinho et al. NATURE
- Polo-like kinases: structural variations lead to multiple functions
- (2014) Sihem Zitouni et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A novel role for Plk4 in regulating cell spreading and motility
- (2014) C O Rosario et al. ONCOGENE
- Methodologies for the establishment of an orthotopic transplantation model of ovarian cancer in mice
- (2014) Cunjian Yi et al. Frontiers of Medicine
- An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma
- (2013) A Linton et al. BRITISH JOURNAL OF CANCER
- Personalizing the Treatment of Pediatric Medulloblastoma: Polo-like Kinase 1 as a Molecular Target in High-Risk Children
- (2013) J. Triscott et al. CANCER RESEARCH
- The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence?
- (2013) B. D. Cholewa et al. CANCER RESEARCH
- Plk1: unexpected roles in DNA replication
- (2013) Ranadip Mandal et al. CELL RESEARCH
- Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma
- (2013) Christian D. Fingas et al. HEPATOLOGY
- Targeting Signaling Pathways in Epithelial Ovarian Cancer
- (2013) Elisabeth Smolle et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells
- (2013) Ding-pei Han et al. MEDICAL SCIENCE MONITOR
- Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma
- (2013) Anca Milea et al. MODERN PATHOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Exploring the Binding Nature of Pyrrolidine Pocket-Dependent Interactions in the Polo-Box Domain of Polo-Like Kinase 1
- (2013) Ravichandran N. Murugan et al. PLoS One
- Polo-like kinase 2 regulates selective autophagic -synuclein clearance and suppresses its toxicity in vivo
- (2013) A. Oueslati et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells
- (2013) Guojun Zhang et al. TUMOR BIOLOGY
- Landscape of chromosome number changes in prostate cancer progression
- (2013) Martin Braun et al. WORLD JOURNAL OF UROLOGY
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Outlier Kinase Expression by RNA Sequencing as Targets for Precision Therapy
- (2013) Vishal Kothari et al. Cancer Discovery
- Polo-like kinase-1 regulates kinetochore–microtubule dynamics and spindle checkpoint silencing
- (2012) Dan Liu et al. JOURNAL OF CELL BIOLOGY
- Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
- (2012) Roel G.W. Verhaak et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic strategies in epithelial ovarian cancer
- (2012) Ayako Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Plk1 negatively regulates PRC1 to prevent premature midzone formation before cytokinesis
- (2012) Chi-Kuo Hu et al. MOLECULAR BIOLOGY OF THE CELL
- NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies
- (2012) B. Valsasina et al. MOLECULAR CANCER THERAPEUTICS
- The functions and regulation of the PTEN tumour suppressor
- (2012) Min Sup Song et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Hormonal Induction of Polo-Like Kinases (Plks) and Impact of Plk2 on Cell Cycle Progression in the Rat Ovary
- (2012) Feixue Li et al. PLoS One
- The Structure of the Plk4 Cryptic Polo Box Reveals Two Tandem Polo Boxes Required for Centriole Duplication
- (2012) Lauren K. Slevin et al. STRUCTURE
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Polo-Box Domain Inhibitor Poloxin Activates the Spindle Assembly Checkpoint and Inhibits Tumor Growth in Vivo
- (2011) Juping Yuan et al. AMERICAN JOURNAL OF PATHOLOGY
- Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions
- (2011) Leonidas Benetatos et al. ANNALS OF HEMATOLOGY
- Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer
- (2011) N. Syed et al. CANCER RESEARCH
- Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
- (2011) Peter Friedl et al. CELL
- Plk2 regulated centriole duplication is dependent on its localization to the centrosome and a functional polo-box domain
- (2011) Onur Cizmecioglu et al. CELL CYCLE
- Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21WAF1/CIP1
- (2011) Nina-Naomi Kreis et al. CELL CYCLE
- From Plk1 to Plk5
- (2011) Guillermo de Cárcer et al. CELL CYCLE
- Anaphase Catastrophe Is a Target for Cancer Therapy
- (2011) Fabrizio Galimberti et al. CLINICAL CANCER RESEARCH
- Upregulation of Polo-like kinase 2 gene expression by GATA-1 acetylation in human osteosarcoma MG-63 cells
- (2011) Tao Shen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- DNA Ploidy is Stronger Than Lymph Node Metastasis as Prognostic Factor in Cervical Carcinoma
- (2011) Tommaso Susini et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Polo-Like Kinase 1 Is a Potential Therapeutic Target in Human Melanoma
- (2011) Ahmad Jalili et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression
- (2011) G. de Carcer et al. MOLECULAR AND CELLULAR BIOLOGY
- Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors
- (2011) David L. Myer et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder
- (2011) Zhe Zhang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
- (2011) Monika Raab et al. Nature Communications
- Polo-Like Kinase 1 as Predictive Marker and Therapeutic Target for Radiotherapy in Rectal Cancer
- (2010) Franz Rödel et al. AMERICAN JOURNAL OF PATHOLOGY
- Polo-like kinase 1 (Plk1) in cutaneous T-cell lymphoma
- (2010) N. Stutz et al. BRITISH JOURNAL OF DERMATOLOGY
- Human Plk4 phosphorylates Cdc25C
- (2010) Sepal Bonni et al. CELL CYCLE
- Polo-like kinase 1 (Plk1) in non-melanoma skin cancers
- (2010) Travis Schmit et al. CELL CYCLE
- Polo-Like Kinase 1 is a Therapeutic Target in High-Risk Neuroblastoma
- (2010) S. Ackermann et al. CLINICAL CANCER RESEARCH
- Phosphorylation of CLIP-170 by Plk1 and CK2 promotes timely formation of kinetochore–microtubule attachments
- (2010) Hongchang Li et al. EMBO JOURNAL
- Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery
- (2010) X Shawn Liu et al. EMBO REPORTS
- RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells
- (2010) Shilpi Arora et al. GYNECOLOGIC ONCOLOGY
- Plk3 Functions as an Essential Component of the Hypoxia Regulatory Pathway by Direct Phosphorylation of HIF-1α
- (2010) Dazhong Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus
- (2010) Zdenek Andrysik et al. NUCLEIC ACIDS RESEARCH
- Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
- (2010) S L Cooke et al. ONCOGENE
- Modulating Polo-Like Kinase 1 as a Means for Cancer Chemoprevention
- (2010) Travis L. Schmit et al. PHARMACEUTICAL RESEARCH
- Plk4 is required for cytokinesis and maintenance of chromosomal stability
- (2010) C. O. Rosario et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 4: the odd one out of the family
- (2010) James E Sillibourne et al. Cell Division
- In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
- (2010) Alexis B. Cordero et al. Jove-Journal of Visualized Experiments
- Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma
- (2009) Rossella Pellegrino et al. HEPATOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma Cells
- (2009) Travis L. Schmit et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Polo-like kinases: conservation and divergence in their functions and regulation
- (2009) Vincent Archambault et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Identification of Genes With Differential Expression in Chemoresistant Epithelial Ovarian Cancer Using High-Density Oligonucleotide Microarrays
- (2009) Woong Ju et al. ONCOLOGY RESEARCH
- Polo-Like Kinase 1 Directs Assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF Complex to Initiate Cleavage Furrow Formation
- (2009) Benjamin A. Wolfe et al. PLOS BIOLOGY
- A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1
- (2008) Wolfgang Reindl et al. ANALYTICAL BIOCHEMISTRY
- Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis
- (2008) P. Finetti et al. CANCER RESEARCH
- Polo-like Kinase 3 Functions as a Tumor Suppressor and Is a Negative Regulator of Hypoxia-Inducible Factor-1 under Hypoxic Conditions
- (2008) Y. Yang et al. CANCER RESEARCH
- Inhibition of Polo-like Kinase 1 by Blocking Polo-Box Domain-Dependent Protein-Protein Interactions
- (2008) Wolfgang Reindl et al. CHEMISTRY & BIOLOGY
- Aberrant Polo-Like Kinase 1-Cdc25A Pathway in Metastatic Hepatocellular Carcinoma
- (2008) X. Q. Wang et al. CLINICAL CANCER RESEARCH
- Targeting signaling pathways in ovarian cancer
- (2008) J Reibenwein et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment
- (2008) Caroline A. Barton et al. GYNECOLOGIC ONCOLOGY
- Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma
- (2008) Yan-Bin Feng et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Dose Escalation and Pharmacokinetic Study of BI 2536, a Novel Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Tumors
- (2008) Klaus Mross et al. JOURNAL OF CLINICAL ONCOLOGY
- Polo-Like Kinase 1 Is Essential for Early Embryonic Development and Tumor Suppression
- (2008) L.-Y. Lu et al. MOLECULAR AND CELLULAR BIOLOGY
- Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression
- (2008) Zheng Fu et al. NATURE CELL BIOLOGY
- Critical Role of CDK5 and Polo-like Kinase 2 in Homeostatic Synaptic Plasticity during Elevated Activity
- (2008) Daniel P. Seeburg et al. NEURON
- Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry
- (2008) A. Seki et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now